# A Clinical Trial of MT200605 for the Treatment of Acute Ischemic Stroke

Study · id `cardio:ct-nct07205328` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07205328](<https://clinicaltrials.gov/study/NCT07205328>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT07205328

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 360 participants.

## Technical summary

Registry record NCT07205328. Randomized; quadruple masking; primary purpose treatment. Start 2025-09-30 (actual); primary completion 2026-06-12 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 360 participants (enrolled count; ClinicalTrials.gov record NCT07205328, source copy `cardio:ctgov-nct07205328-2026-11-12`, retrieved 2026-11-18)
- Started: 2025-09-30 (actual) (ClinicalTrials.gov record NCT07205328, source copy `cardio:ctgov-nct07205328-2026-11-12`, retrieved 2026-11-18)
- Primary completion: 2026-06-12 (actual) (ClinicalTrials.gov record NCT07205328, source copy `cardio:ctgov-nct07205328-2026-11-12`, retrieved 2026-11-18)
- Completion: 2026-06-12 (actual) (ClinicalTrials.gov record NCT07205328, source copy `cardio:ctgov-nct07205328-2026-11-12`, retrieved 2026-11-18)
- Countries: China (ClinicalTrials.gov record NCT07205328, source copy `cardio:ctgov-nct07205328-2026-11-12`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07205328-2026-11-12`, retrieved 2026-11-18)

## The registry's words

- Brief title: A Clinical Trial of MT200605 for the Treatment of Acute Ischemic Stroke
- Condition: Acute Ischemic Stroke
- Intervention (Drug): MT200605
- Intervention (Drug): MT200605
- Intervention (Drug): MT200605
- Intervention (Drug): Placebo
- Lead sponsor: Shaanxi Micot Pharmaceutical Technology Co., Ltd.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)

## Provenance

Content hash: b193f4beb7586626dcc99520344dcda83930d8cb5da993f0e7be8182c5162ecd
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
